Co-Diagnostics Inc (CODX)

$0.28 -0.01 (-3.15%)
Market Cap 9.60M
Revenue (ttm) 3.92M
Net Income (ttm) -37.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -960.20%
Debt to Equity Ratio 0.00
Volume 384,800
Avg Vol 433,810
Day's Range N/A - N/A
Shares Out 33.57M
Stochastic %K 72%
Beta 0.60
Analysts Sell
Price Target $5.50

Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus...

Industry: Medical Devices
Sector: Healthcare
Phone: (801) 438-1036
Website: co-dx.com
Address:
2401 S. Foothill Dr., Suite D, Salt Lake City, United States
diamondhope
diamondhope Jul. 4 at 4:09 PM
$CODX imo https://ca.marketscreener.com/quote/stock/CO-DIAGNOSTICS-INC-35952882/news/Tranche-Update-on-Co-Diagnostics-Inc-s-Equity-Buyback-Plan-announced-on-March-15-2022-44672835/ "From April 1, 2023 to June 30, 2023, the company has repurchased 368,809 shares, representing 1.2% for $0.56 million. With this, the company has completed the repurchase of 4,559,479 shares, representing 13.81% for $15.26 million under the buyback announced on March 15, 2022." Wouldn't it be Great if Co-Dx still had that $15.26 million? LEADERSHIP or VANITY
2 · Reply
SmallPhish
SmallPhish Jul. 4 at 3:34 AM
$CODX BBQ at Dwight’s house on Friday
1 · Reply
Allyofall2
Allyofall2 Jul. 4 at 12:47 AM
$CODX Have a great weekend kingdom. Happy 4th of July America 🇺🇸.
1 · Reply
tatanka9
tatanka9 Jul. 3 at 5:22 PM
$CODX Dwight! Do us and yourself a favor quit. f**ken loser!
3 · Reply
dwadmi
dwadmi Jul. 3 at 6:30 AM
$ASBP I think, regardless RS or not, this will be huge in Q3 Planning to move all money i have in $CLDI $CODX $MKDW and $ZBAI to $ASBP BUZZ BOMB will take it to 2-digit shares
1 · Reply
Minutiae
Minutiae Jul. 2 at 11:59 PM
$CODX Jul 2 CODX short volume 54% out of an 85,660 trade volume closing at $0.286. FINRA Short Sales Volume 24,438 shorted shares out of 45,420. 1,525 after-hour shares traded at $0.2756 to $0.30 so far.
0 · Reply
dwadmii
dwadmii Jul. 2 at 1:23 PM
$CODX soon 1x
0 · Reply
Antiquarian
Antiquarian Jul. 2 at 12:24 PM
$CODX
0 · Reply
Minutiae
Minutiae Jul. 2 at 8:01 AM
$CODX Further comment: CRISPR-Driven Electrochemical Sensors Usher in an Era of Affordable Disease Diagnostics By Forward Pathway | Posted on July 1, 2025 https://www.forwardpathway.us/crispr-driven-electrochemical-sensors-usher-in-an-era-of-affordable-disease-diagnostics
0 · Reply
Nik_CA
Nik_CA Jul. 2 at 1:51 AM
$CODX DE needs to buckle up as he is running out of both, time and cash. Newer and cheaper technologies are emerging as we speak. https://apple.news/AQuD3kCIARJO3J9UU1zKBsg
1 · Reply
Latest News on CODX
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference

May 14, 2025, 9:30 AM EDT - 7 weeks ago

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference

Co-Diagnostics, Inc. (CODX) Q1 2025 Earnings Call Transcript

May 8, 2025, 9:59 PM EDT - 2 months ago

Co-Diagnostics, Inc. (CODX) Q1 2025 Earnings Call Transcript

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results

May 8, 2025, 4:01 PM EDT - 2 months ago

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast

Apr 29, 2025, 7:30 AM EDT - 2 months ago

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast

Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 6:44 PM EDT - 3 months ago

Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript

Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results

Mar 27, 2025, 4:01 PM EDT - 3 months ago

Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast

Mar 13, 2025, 9:30 AM EDT - 4 months ago

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025

Mar 3, 2025, 9:30 AM EST - 4 months ago

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Feb 24, 2025, 8:18 AM EST - 4 months ago

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

Feb 21, 2025, 4:00 PM EST - 4 months ago

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025

Jan 7, 2025, 9:30 AM EST - 6 months ago

Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility

Dec 10, 2024, 9:30 AM EST - 7 months ago

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility

Co-Diagnostics, Inc. (CODX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 8:49 PM EST - 8 months ago

Co-Diagnostics, Inc. (CODX) Q3 2024 Earnings Call Transcript

Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 4:01 PM EST - 8 months ago

Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results

Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024

Nov 5, 2024, 9:30 AM EST - 8 months ago

Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024

Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast

Oct 25, 2024, 4:01 PM EDT - 8 months ago

Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast

Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024

Oct 21, 2024, 9:30 AM EDT - 9 months ago

Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024

Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3

Oct 2, 2024, 9:30 AM EDT - 9 months ago

Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3

Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan

Sep 24, 2024, 9:30 AM EDT - 10 months ago

Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan

Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test

Sep 5, 2024, 9:30 AM EDT - 10 months ago

Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test

Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C.

Aug 15, 2024, 9:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C.

Co-Diagnostics, Inc. (CODX) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 11:14 AM EDT - 11 months ago

Co-Diagnostics, Inc. (CODX) Q2 2024 Earnings Call Transcript

Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 4:01 PM EDT - 11 months ago

Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results

Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago

Jul 29, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago

Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast

Jul 25, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast

Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States

Jul 2, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States

Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21

Jun 18, 2024, 1:30 PM EDT - 1 year ago

Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21

Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform

Jun 14, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform

Co-Diagnostics, Inc. (CODX) Q1 2024 Earnings Call Transcript

May 9, 2024, 9:30 PM EDT - 1 year ago

Co-Diagnostics, Inc. (CODX) Q1 2024 Earnings Call Transcript

Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results

May 9, 2024, 4:01 PM EDT - 1 year ago

Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results

Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast

Apr 25, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast

Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan

Apr 24, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan

Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event

Apr 12, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event

Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions

Apr 4, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions

Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address

Mar 21, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address

Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England

Mar 18, 2024, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England

Co-Diagnostics, Inc. (CODX) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 9:19 PM EDT - 1 year ago

Co-Diagnostics, Inc. (CODX) Q4 2023 Earnings Call Transcript

Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results

Mar 14, 2024, 4:01 PM EDT - 1 year ago

Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test

Mar 7, 2024, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast

Feb 29, 2024, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast

Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024

Feb 1, 2024, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024

Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro

Dec 27, 2023, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro

Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023

Nov 29, 2023, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023

Co-Diagnostics, Inc. (CODX) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 7:59 PM EST - 1 year ago

Co-Diagnostics, Inc. (CODX) Q3 2023 Earnings Call Transcript

Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Nov 9, 2023, 4:01 PM EST - 1 year ago

Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development

Nov 2, 2023, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development

Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for November 2023

Oct 31, 2023, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for November 2023

Co-Diagnostics, Inc. Announces Third Quarter 2023 Earnings Release Date and Webcast

Oct 26, 2023, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Announces Third Quarter 2023 Earnings Release Date and Webcast

Co-Diagnostics, Inc. to Host Booth at CASMET Symposium October 23-25

Oct 23, 2023, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. to Host Booth at CASMET Symposium October 23-25

Sustainable Infrastructure Dividend ETF Distributions

Oct 23, 2023, 9:18 AM EDT - 1 year ago

Sustainable Infrastructure Dividend ETF Distributions

diamondhope
diamondhope Jul. 4 at 4:09 PM
$CODX imo https://ca.marketscreener.com/quote/stock/CO-DIAGNOSTICS-INC-35952882/news/Tranche-Update-on-Co-Diagnostics-Inc-s-Equity-Buyback-Plan-announced-on-March-15-2022-44672835/ "From April 1, 2023 to June 30, 2023, the company has repurchased 368,809 shares, representing 1.2% for $0.56 million. With this, the company has completed the repurchase of 4,559,479 shares, representing 13.81% for $15.26 million under the buyback announced on March 15, 2022." Wouldn't it be Great if Co-Dx still had that $15.26 million? LEADERSHIP or VANITY
2 · Reply
SmallPhish
SmallPhish Jul. 4 at 3:34 AM
$CODX BBQ at Dwight’s house on Friday
1 · Reply
Allyofall2
Allyofall2 Jul. 4 at 12:47 AM
$CODX Have a great weekend kingdom. Happy 4th of July America 🇺🇸.
1 · Reply
tatanka9
tatanka9 Jul. 3 at 5:22 PM
$CODX Dwight! Do us and yourself a favor quit. f**ken loser!
3 · Reply
dwadmi
dwadmi Jul. 3 at 6:30 AM
$ASBP I think, regardless RS or not, this will be huge in Q3 Planning to move all money i have in $CLDI $CODX $MKDW and $ZBAI to $ASBP BUZZ BOMB will take it to 2-digit shares
1 · Reply
Minutiae
Minutiae Jul. 2 at 11:59 PM
$CODX Jul 2 CODX short volume 54% out of an 85,660 trade volume closing at $0.286. FINRA Short Sales Volume 24,438 shorted shares out of 45,420. 1,525 after-hour shares traded at $0.2756 to $0.30 so far.
0 · Reply
dwadmii
dwadmii Jul. 2 at 1:23 PM
$CODX soon 1x
0 · Reply
Antiquarian
Antiquarian Jul. 2 at 12:24 PM
$CODX
0 · Reply
Minutiae
Minutiae Jul. 2 at 8:01 AM
$CODX Further comment: CRISPR-Driven Electrochemical Sensors Usher in an Era of Affordable Disease Diagnostics By Forward Pathway | Posted on July 1, 2025 https://www.forwardpathway.us/crispr-driven-electrochemical-sensors-usher-in-an-era-of-affordable-disease-diagnostics
0 · Reply
Nik_CA
Nik_CA Jul. 2 at 1:51 AM
$CODX DE needs to buckle up as he is running out of both, time and cash. Newer and cheaper technologies are emerging as we speak. https://apple.news/AQuD3kCIARJO3J9UU1zKBsg
1 · Reply
Minutiae
Minutiae Jul. 1 at 11:12 PM
$CODX Jul 1 CODX short volume 45% out of a 165,958 trade volume closing at $0.278. FINRA Short Sales Volume 56,237 shorted shares out of 125,163. 4,987 after-hour shares traded at $0.2701 to $0.2838 so far.
0 · Reply
tatanka9
tatanka9 Jul. 1 at 11:02 PM
$CODX CEO needs to go! Pathetic!
0 · Reply
diamondhope
diamondhope Jul. 1 at 5:55 PM
$CODX IMO https://genius.com/Carly-simon-youre-so-vain-lyrics "I had some dreams, they were clouds in my coffee" This. Contrasted against jet-setting.
0 · Reply
Millones
Millones Jul. 1 at 4:15 PM
$CODX
2 · Reply
Wannbe
Wannbe Jul. 1 at 1:26 PM
$CODX
0 · Reply
wasserschlag10
wasserschlag10 Jul. 1 at 6:14 AM
$CODX What happened to this 50 $ stock. ??
0 · Reply
Antiquarian
Antiquarian Jul. 1 at 1:52 AM
$CODX
0 · Reply
Minutiae
Minutiae Jun. 30 at 9:41 PM
$CODX Jun 30 CODX short volume 80% out of a 193,967 trade volume closing at $0.2802. FINRA Short Sales Volume 135,406 shorted shares out of 169,486. 5 after-hour shares traded at $0.2751 to $0.2801 so far. The shorts provided and controlled nearly all of today's volume and trading activity.
0 · Reply
Pyranha
Pyranha Jun. 30 at 12:23 PM
$CODX last day of first half of the year…. What a disappointing half. Here’s to a successful second half 🥂 🍻 (knock wood 🪵) Let’s try remain positive and help each other reach Xmas alive. GLTA
0 · Reply
Minutiae
Minutiae Jun. 30 at 6:30 AM
$CODX An 8-page batch of FDA 510(k) Premarket Notifications was released on Jun 30 in the early am. 1 molecular test is in this batch of 510(k) notifications. Decision Dates 06/23/2025 - 06/29/2025 Lab-based hiv nat diagnostic and/or supplemental test BK251233 cobas® HIV-1/HIV-2 Qualitative Nucleic acid test for use on the cobas® 5800/6800/8800 systems Human Immunodeficiency Virus (HIV) Nucleic Acid (NAT) Diagnostic And/Or Supplemental Test Roche Molecular Systems, Inc. Classification Product Code QST Date Received 05/29/2025 Decision Date 06/27/2025 (Click on the "Search" button to have a look) https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm
0 · Reply
diamondhope
diamondhope Jun. 29 at 9:12 PM
$CODX IMO Can AI help Co-Dx? Streamline, reduce costs, trim workforce? Does Co-Dx still need over 100+ employees? Can some employees be put "on Hold" until we recover? How much could Co-Dx get if they sold just the PCR Pro facility and also included all the Licenses for all the IP needed to keep the plant running? There are many ways Co-Dx can modify the ownership and leadership of the company before having to entertain Bankruptcy, if they so desire. Keeping current leadership in the Driver's seat does not seem like the strongest option for preserving capital. The old insiders must let go of their stranglehold if they truly want the best for all concerned; employees, shareholders, future patients.
0 · Reply
Antiquarian
Antiquarian Jun. 28 at 1:24 AM
$CODX good night have a great weekend
0 · Reply